Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hauschild

Showing results (31-40 of 342) with videos related to

Pageof 35
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Axel Hauschild, Thomas Dirschka, Dirk Schadendorf, et al.
The New England Journal of Medicine|February 15, 2018
Adjuvant Therapy in Resected MelanomaGeorgina V Long, Axel Hauschild, John M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Management of immune-related adverse events and kinetics of response with ipilimumabJeffrey S Weber, Katharina C Kähler, Axel Hauschild
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 24, 2021
[Local tumor control of metastatic Merkel cell carcinoma in a 90-year-old woman]Katja Dicke, Vasileios Dervenis, Axel Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Rare haematologic and neurologic drug reactions from immune checkpoint inhibition in a responding patient with metastatic anorectal mucosal melanomaSarah Qaiyumi, Wolfram Klapper, Axel Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Immune checkpoint blockade for organ-transplant recipients with cancer: A reviewAlessandra Rünger, Dirk Schadendorf, Axel Hauschild, et al.
Onkologie|April 21, 2012
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Archives of Dermatology|September 17, 2008
Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruptionElisabeth Eiling, Michael Brandt, Thomas Schwarz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Melanoma Research|June 11, 2009
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patientKatharina C Kaehler, Friederike Egberts, Paul Lorigan, et al.
Pageof 35

Showing results (31-40 of 342) with videos related to

Sort By:
Pageof 35
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Axel Hauschild, Thomas Dirschka, Dirk Schadendorf, et al.
The New England Journal of Medicine|February 15, 2018
Adjuvant Therapy in Resected MelanomaGeorgina V Long, Axel Hauschild, John M Kirkwood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Management of immune-related adverse events and kinetics of response with ipilimumabJeffrey S Weber, Katharina C Kähler, Axel Hauschild
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 24, 2021
[Local tumor control of metastatic Merkel cell carcinoma in a 90-year-old woman]Katja Dicke, Vasileios Dervenis, Axel Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Rare haematologic and neurologic drug reactions from immune checkpoint inhibition in a responding patient with metastatic anorectal mucosal melanomaSarah Qaiyumi, Wolfram Klapper, Axel Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
Immune checkpoint blockade for organ-transplant recipients with cancer: A reviewAlessandra Rünger, Dirk Schadendorf, Axel Hauschild, et al.
Onkologie|April 21, 2012
[Foreword]Axel Hauschild, Oliver Kölbl, Andreas Mackensen, et al.
Archives of Dermatology|September 17, 2008
Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruptionElisabeth Eiling, Michael Brandt, Thomas Schwarz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Melanoma Research|June 11, 2009
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patientKatharina C Kaehler, Friederike Egberts, Paul Lorigan, et al.
Pageof 35